SynthesisMedicine2022

Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials.

Dun-Chang Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.